InVivo Therapeutics Holdings Corporation
InVivo Therapeutics Holdings Corporation (NVIV) Revenue
Annual & quarterly revenue history · segment & region breakdown
NVIV · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsInVivo Therapeutics Holdings Corporation trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income InVivo Therapeutics Holdings Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
InVivo Therapeutics Holdings Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from InVivo Therapeutics Holdings Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
NVIV revenue · 4 questionsNVIV's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · InVivo Therapeutics Holdings Corporation SEC filings · GAAP · InVivo Therapeutics Holdings Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026